Startup Opportunities in Biotechnology
Abstract/Contents
- Abstract
- Scheller, Richard, Genentech's Executive Vice President of Research and Early Development, believes it is unlikely, if not impossible, for small companies to push drug products through the final stage of development. However, Scheller also thinks a smart biotechnology startup could do early stage development and then turn to larger firms for product licensing or acquisition. Scheller also discusses the state of research and development at Genentech, in comparison to other firms.
Description
| Type of resource | moving image |
|---|---|
| Extent | 1 digital video file |
| Place | Stanford (Calif.) |
| Date created | April 27, 2011 |
| Language | English |
| Digital origin | born digital |
| Sound content | sound |
| Color content | color |
Creators/Contributors
| Speaker | Scheller, Richard |
|---|
Subjects
| Subject | Entrepreneurship |
|---|---|
| Subject | Business |
| Genre | Filmed lectures |
Bibliographic information
| Location | https://purl.stanford.edu/fj030fk4050 |
|---|---|
| Location | SC1209 |
| Repository | Stanford University. Libraries. Department of Special Collections and University Archives |
Access conditions
- Use and reproduction
- The materials are open for research use and may be used freely for non-commercial purposes with an attribution. For commercial permission requests, please contact the Stanford University Archives (archivesref@stanford.edu).
- Copyright
- Copyright © 2011 The Board of Trustees of the Leland Stanford Junior University. All rights reserved.
Collection
Stanford Technology Ventures Program, Entrepreneurial Thought Leaders Seminar, videorecordings
View other items in this collection in SearchWorksAlso listed in
Loading usage metrics...